N@N

Market Maker Surveillance Report. MRK, CIM, ABT, HPQ, CLWR, ALQA, Bullishly Biased Price Friction For Tuesday, January 8th 201

January 8, 2013 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3949 companies with "abnormal" market making, 2552 companies with positive Friction Factors and 2778 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. Merck & Co Inc (NYSE:MRK), Chimera Investment Corp (NYSE:CIM), ABBOTT LABORATORIES (NYSE:ABT), Hewlett-Packard Co (NYSE:HPQ), Clearwire Corp (NASDAQ:CLWR), Alliqua Inc (OTC:ALQA). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  MRK     $0.060    0.15%     2,872,287    19.70%    5,685,251    38.99%    -2,812,964   Abnormal
  CIM     $0.040    1.46%     5,518,362    28.55%    8,403,876    43.49%    -2,885,514   Abnormal
  ABT     $0.010    0.03%     3,529,811    23.76%    5,569,687    37.49%    -2,039,876   Abnormal
  HPQ     $0.040    0.26%     10,434,206   31.78%    12,646,465   38.52%    -2,212,259   Abnormal
  CLWR    $0.020    0.69%     3,550,588    39.64%    5,406,315    60.36%    -1,855,727   Abnormal
  ALQA    $0.011    24.44%    1,009,382    18.75%    4,375,321    81.25%    -3,365,939   Abnormal

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above had more selling than buying on Tuesday and their stock prices rose. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows MRK with 2,812,964 greater shares of selling than buying (NetVol) and the stock price was up $0.06000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more selling than buying should cause prices to drop.

Merck & Co Inc (NYSE:MRK) - Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, immunology infectious diseases, neurosciences and ophthalmology, oncology, vaccines, and women's health and endocrine. It also offers vaccines, including preventive pediatric, adolescent, and adult vaccines. In addition, the company discovers, develops, manufactures, and markets antibiotics, anti-inflammatory products, vaccines, products for the treatment of fertility disorders, and parasiticides for cattle, swine, horses, poultry, dogs, cats, salmons, and fish. Further, it manufactures and sells over-the-counter product line, including non-drowsy antihistamines; treatment for occasional constipation; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant spray; and treatment for frequent heartburn. Additionally, the company provides foot care products comprising topical antifungal, and foot and sneaker odor/wetness products; and sun care products consisting of sun care lotions, sprays, and dry oils. It serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, and managed health care providers, as well as food chain and mass merchandiser outlets in the United States and internationally. The company has joint venture agreements with Sanofi Pasteur S.A. and AstraZeneca LP. Merck & Co., Inc. was founded in 1891 and is headquartered in Whitehouse Station, New Jersey..

Chimera Investment Corp (NYSE:CIM) - Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in residential mortgage-backed securities (RMBS), residential mortgage loans, commercial mortgage loans, real estate-related securities, and other asset classes. Its targeted asset classes include agency or non-agency RMBS; prime, jumbo prime, and Alt-A mortgage loans; first or second lien loans secured by multifamily properties, mixed residential or other commercial properties, retail properties, office properties, or industrial properties; and asset-based securities (ABS), including commercial mortgage-backed securities, debt and equity tranches of collateralized debt obligations, and consumer and non-consumer ABS. The company has elected to be treated as a REIT for federal income tax purposes and would not be subject to income tax, if it distributes at least 90% of its REIT taxable income to its share holders. Chimera Investment Corporation was founded in 2007 and is based in New York, New York..

ABBOTT LABORATORIES (NYSE:ABT) - Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company offers adult and pediatric pharmaceuticals for rheumatoid and psoriatic arthritis, ankylosing spondylitis, psoriasis, juvenile idiopathic arthritis, and Crohn s disease; dyslipidemia; HIV infection; prostate cancer, endometriosis and central precocious puberty, and anemia caused by uterine fibroids; respiratory syncytial virus; adult males who have low testosterone; secondary hyperparathyroidism; hypothyroidism; and pancreatic exocrine insufficiency, as well as anesthesia products. It also offers diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and/or diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis. In addition, the company provides coronary, endovascular, vessel closure, and structural heart devices, such as drug-eluting stent systems, coronary metallic stents, balloon dilatation products, coronary guidewires, carotid stent systems, valve repair systems, and drug-eluting bioresorbable vascular products. Further, it offers branded generic pharmaceuticals; pediatric and adult nutritional products; blood glucose monitoring meters, test strips, data management software, and accessories for people with diabetes; and medical devices for the eye, such as cataract surgery, LASIK surgery, and contact lens care and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians offices, and government agencies. Abbott Laboratories was founded in 1888 and is headquartered in Abbott Park, Illinois..

Hewlett-Packard Co (NYSE:HPQ) - Hewlett-Packard Company and its subsidiaries provide products, technologies, software, solutions, and services to individual consumers and small- and medium-sized businesses (SMBs), as well as to the government, health, and education sectors worldwide. Its Personal Systems Group segment offers commercial personal computers (PCs), consumer PCs, workstations, calculators and other related accessories, and software and services for the commercial and consumer markets. The company s Services segment provides consulting, outsourcing, and technology services to infrastructure, applications, and business process domains. Its Imaging and Printing Group segment provides consumer and commercial printer hardware, supplies, media, and scanning devices, such as inkjet and Web solutions, laser jet and enterprise solutions, managed enterprise solutions, graphics solutions, and printer supplies. The company s Enterprise Servers, Storage, and Networking segment offers industry standard servers, business critical systems, storage platforms, and networking products, including switches, routers, wireless LAN, and TippingPoint network security products. Its HP Software segment provides enterprise IT management software, information management solutions, and security intelligence/risk management solutions. The company s HP Financial Services segment offers leasing, financing, utility programs, and asset recovery services; and financial asset management services for enterprise customers, as well as specialized financial services to SMBs, and educational and governmental entities. Hewlett-Packard Company also provides business intelligence solutions that enable businesses to standardize on consistent data management schemes, connect and share data across the enterprise, and apply analytics, as well as licenses its specific technology to third parties. The company was founded in 1939 and is headquartered in Palo Alto, California..

Clearwire Corp (NASDAQ:CLWR) - Clearwire Corporation, through its subsidiaries, provides fourth generation wireless broadband services in the United States. The company builds and operates mobile broadband networks that offer high-speed mobile Internet and residential Internet access services. It serves retail customers through its CLEAR brand. The company markets its products and services directly to consumers, as well as through cellular retailers, consumer electronics stores, satellite television dealers, and computer sales and repair stores; and through company-operated retail outlets. As of October 25, 2012, it had 1.4 million retail subscribers and 9.1 million wholesale subscribers. As of October 2012, Clearwire Corporation operates as s subsidiary of Sprint Nextel Corp..

Alliqua Inc (OTC:ALQA) - Alliqua, Inc., an advanced biomedical products company, focuses on the development and manufacturing of proprietary technologies in the fields of drug delivery, wound care, and liver health preservation. The company, through its subsidiaries, develops, manufactures, and markets water content, electron beam cross-linked, and aqueous polymer hydrogels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. Its products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies. The company also focuses on the development of proprietary products for wound care dressings, and a transdermal delivery technology platform to deliver drugs and other beneficial ingredients through the skin. In addition, it offers HepaMate, an extracorporeal cell-based bio-artificial liver support system designed to provide whole liver function to patients with acute or severe liver failure. The company is headquartered in New York, New York..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net

Contributing Sources

---